Research about heart failure (HF) has made major progress in the last years. We give here
an update on the most recent findings. Landmark trials have established new treatments for …

Substantial progress in the field of mechanical circulatory support (MCS) has expanded the
treatment options for patients with advanced-stage heart failure (HF). Currently available …

Aim The MOMENTUM 3 pivotal trial established superiority of the HeartMate 3 (HM3) left
ventricular assist device (LVAD), a fully magnetically levitated centrifugal‐flow pump, over …

The drive-line to power contemporary ventricular assist devices exiting the skin is associated
with infection, and requires a holstered performance of the cardiac pump, which reduces …

Abstract Background In the MOMENTUM 3 (Multicenter Study of MagLev Technology in
Patients Undergoing Mechanical Circulatory Support Therapy with HeartMate 3) pivotal trial …

Abstract Aims The ELEVATE Registry was designed to study long-term outcomes with the
Heartmate 3 (HM3), a fully magnetically levitated centrifugal ventricular assist device, in a …

Background: Hemodynamic ramp (HR) tests can guide the optimization of left ventricular
assist device (LVAD) speed and direct medical therapy. We investigated the effects of HR …

Aims Left ventricular assist device (LVAD) therapy improves the haemodynamics of
advanced heart failure patients. However, it is unknown whether haemodynamic …

Background End stage heart failure is a major cause of morbidity and mortality, and its
prevalence is expected to rise with the ageing population. For suitable patients, orthotopic …

The HeartWare HVAD System (Medtronic) is a durable left ventricular assist device (LVAD)
approved for bridge to transplant indication in 2012 and destination therapy indication in …